Aust Vet J 2013;91:312–319. DOI: 10.1111/avj.12080
Bioequivalence of a new liquid formulation of benazepril compared with the reference tablet product
K Kelers, JL Devi, GA Anderson, P Zahra, JH Vine and T Whittem
The editors wish to correct the following typographical errors in this article:
1. The analytical procedures section of the Materials and methods, lines 10–15 of the second paragraph, should read:
The dried extract was reconstituted in mobile phase (1% acetic acid: methanol, 95:5 v/v, 200 μL) for liquid chromatography mass spectrometry analysis performed on a Quantum Access triple quadrupole mass spectrometer (Thermo Fisher) coupled to a 1200 series binary pump (Agilent Technologies).
2. Lines 5–7 of the third paragraph of the Analytical procedures section should read:
Transitions (relative collision energy) of 1 ms2 for each analyte were chosen and used for quantitation as follows: benazepril m/z 425.1→351.0 (20%), benazepril-d5 m/z 430.1 → 356.0 (20%), benazeprilat m/z 397.1 → 351.0 (18%) and benazeprilat-d5 m/z 402.1 → 356.0 (18%).
3. Table 1 was unfortunately laid out incorrectly in the original article. The correct version is as follows:
|AUC(0–10) (%inhibition.h)||AUC (h.µg/L)||Cmax (μg/L)||AUC (h.µg/L)||AUMC (h2.µg/L)||Cl/F (L/h/kg)||MRT (h)|
|Group B (with outlier)|
|Group B (without outlier)b|
4. In Table 2, ACE should be aligned left.